
Lhyfe SA
EPA:LHYFE.PA
3.235 (EUR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3.427 | 1.672 | 0.93 | 0.387 | 0.293 | 0.277 | 0.197 | 0 | 0.002 | 0.002 | 0 | 0 |
Cost of Revenue
| 23.442 | 0.664 | 0.72 | 12.251 | 8.477 | 5.98 | 3.107 | 0.077 | 0.005 | 0.005 | 0 | 0 |
Gross Profit
| -20.015 | 1.008 | 0.21 | -11.864 | -8.184 | -5.703 | -2.91 | -0.077 | -0.004 | -0.004 | 0 | 0 |
Gross Profit Ratio
| -5.84 | 0.603 | 0.226 | -30.656 | -27.932 | -20.588 | -14.772 | 0 | -2.333 | -2.333 | 0 | 0 |
Reseach & Development Expenses
| 0 | 1.121 | 0 | 0 | 0 | 0 | 0 | 0 | 0.071 | 0.071 | 0 | 0 |
General & Administrative Expenses
| 0 | 12.639 | 16.816 | 4.457 | 3.51 | 1.664 | 1.154 | 1.889 | 0.189 | 0.189 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0.288 | 0.438 | 0.175 | 0.166 | 0.141 | 0.047 | 0.047 | 0 | 0 | 0 | 0 |
SG&A
| 0 | 12.927 | 16.962 | 4.631 | 3.675 | 1.804 | 1.201 | 1.936 | 0.189 | 0.189 | 0.285 | 0.285 |
Other Expenses
| -1.085 | 0.221 | 2.846 | 0.252 | 0.445 | 0.803 | 0.285 | 0.169 | 0.385 | 0.385 | 0 | 0 |
Operating Expenses
| -1.085 | 14.269 | 19.66 | 4.379 | 3.23 | 1.001 | 0.916 | 1.767 | 0.645 | 0.645 | 0.272 | 0.272 |
Operating Income
| -18.93 | -13.261 | -17.731 | -16.243 | -11.414 | -6.704 | -3.826 | -1.844 | -0.649 | -0.649 | -0.284 | -0.284 |
Operating Income Ratio
| -5.524 | -7.931 | -19.066 | -41.972 | -38.956 | -24.202 | -19.421 | 0 | -432.333 | -432.333 | 0 | 0 |
Total Other Income Expenses Net
| 3.735 | -0.725 | 0.515 | 0.642 | -0.457 | -7.233 | -2.976 | -0.078 | -0.151 | -0.151 | -0.04 | -0.04 |
Income Before Tax
| -15.195 | -13.986 | -17.612 | -15.601 | -11.871 | -13.937 | -6.802 | -1.922 | -0.8 | -0.8 | -0.324 | -0.324 |
Income Before Tax Ratio
| -4.434 | -8.365 | -18.938 | -40.313 | -40.515 | -50.314 | -34.528 | 0 | -533 | -533 | 0 | 0 |
Income Tax Expense
| 0 | 11.216 | 0.886 | 0.291 | 0.004 | 0 | 0 | 0 | 0.146 | 0.146 | 0 | 0 |
Net Income
| -15.121 | -13.97 | -17.596 | -15.892 | -11.882 | -13.937 | -6.802 | -1.922 | -0.946 | -0.946 | -0.324 | -0.324 |
Net Income Ratio
| -4.412 | -8.355 | -18.92 | -41.065 | -40.553 | -50.314 | -34.528 | 0 | -630.333 | -630.333 | 0 | 0 |
EPS
| -0.32 | -0.29 | -0.36 | -0.33 | -0.25 | -0.29 | -0.14 | -0.04 | -0.049 | -0.049 | -0.025 | -0.025 |
EPS Diluted
| -0.32 | -0.29 | -0.36 | -0.33 | -0.25 | -0.29 | -0.14 | -0.04 | -0.049 | -0.049 | -0.025 | -0.025 |
EBITDA
| -17.408 | -12.59 | -15.684 | -14.49 | -10.523 | -7.351 | -3.662 | -1.739 | -0.633 | -0.633 | -0.283 | -0.283 |
EBITDA Ratio
| -5.08 | -7.53 | -16.865 | -37.442 | -35.915 | -26.538 | -18.589 | 0 | -421.667 | -421.667 | 0 | 0 |